Key result
Continuous infusion of 5-hydroxytryptamine at /kg/min in dogs increased mean pulmonary pressure by 300% and pulmonary resistance by 500%, while decreasing systemic resistance by 55%.
Why the study?
Does continuous infusion of 5-hydroxytryptamine alter pulmonary and systemic hemodynamics in dogs?
Does continuous infusion of 5-hydroxytryptamine alter pulmonary and systemic hemodynamics in dogs?
Continuous infusion of serotonin in dogs acts as a powerful pulmonary vasoconstrictor and peripheral vasodilator, suggesting a potential role in the development of pulmonary hypertension in congenital heart disease.
Answers are grounded in this paper and cite their sources.
Highlights serotonin's pulmonary vasoconstrictor effects in dogs; leaves open its role in congenital heart disease-associated pulmonary hypertension.
The pulmonary and systemic vascular responses to continuous venous infusion of 5-hydroxytryptamine were studied in eight dogs. Chronic catheterization of the pulmonary artery, aorta, and in some animals, the left auricle, permitted repeated studies in the same animal. Infusion rates as low as 20 µg/kg/min. of serotonin creatinine sulfate resulted in a twofold increase of pulmonary arterial pressure. In 11 experiments with an infusion rate of 150 µg/kg/min. there was a 300% increase of mean pulmonary pressure, a 28% drop in systemic arterial mean pressure, and a 60% rise of cardiac output. Calculated pulmonary resistances markedly increased to 500% of control levels, but in contrast, systemic resistances decreased by 55%. 5-Hydroxytryptamine is a powerful vasoconstrictor of the pulmonary vessels and a vasodilator of peripheral vessels, when administered by continuous infusion, and these effects persist as long as the drug is administered. The possible role of 5-hydroxytryptamine in production of pulmonary hypertension in congenital heart disease is considered.
No takes yet. Share an insight, caveat, or question.
Rudolph et al. (1957) studied this question. 5-Hydroxytryptamine (Serotonin) vs. Baseline/control levels was evaluated on Pulmonary and systemic vascular responses (pulmonary arterial pressure, systemic arterial pressure, cardiac output, and resistances). Continuous infusion of 5-hydroxytryptamine at /kg/min in dogs increased mean pulmonary pressure by 300% and pulmonary resistance by 500%, while decreasing systemic resistance by 55%.
Synapse has enriched 10 related papers. Consider them for comparative context: